Ann Dermatol.  2009 Aug;21(3):323-325. 10.5021/ad.2009.21.3.323.

A Case of Acute Generalized Exanthematous Pustulosis Possibly Induced by Ritodrine

• Won JH
• Yun SJ
• Kim SJ
• Lee SC
• Won YH
• Lee JB

• KMID: 2266303
• DOI: http://doi.org/10.5021/ad.2009.21.3.323

Abstract

Acute generalized exanthematous pustulosis is a skin reaction characterized by an acute onset, fever, and a cutaneous eruption with non-follicular sterile pustules on edematous erythema. It mimics many of the features of pustular psoriasis but is differentiated by its characteristic clinical course and history. The cause is usually ingested drugs. We report a case of acute generalized exanthematous pustulosis possibly induced by ritodrine

Keyword

Acute generalized exanthematous pustulosis; Ritodrine

MeSH Terms

Acute Generalized Exanthematous Pustulosis
Erythema
Fever
Psoriasis
Ritodrine
Skin
Ritodrine

Figure

• 

  Fig. 1 Skin lesions presenting as tiny superficial pustules and scales on a broad erythematous patch over the entire torso.

• 

  Fig. 2 Histological findings show subcorneal pustules but no epidermal hyperplasia (H&E, ×100).

Reference

1. Beylot C, Bioulac P, Doutre MS. Acute generalized exanthematic pustuloses (four cases). Ann Dermatol Venereol. 1980. 107:37–48.

2. Yaju Y, Nakayama T. Effectiveness and safety of ritodrine hydrochloride for the treatment of preterm labour: a systematic review. Pharmacoepidemiol Drug Saf. 2006. 15:813–822.

3. Beylot C, Doutre MS, Beylot-Barry M. Acute generalized exanthematous pustulosis. Semin Cutan Med Surg. 1996. 15:244–249.

4. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol. 2001. 28:113–119.

5. Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007. 157:989–996.

6. Wolkenstein P, Chosidow O, Flechet ML, Robbiola O, Paul M, Dume L, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis. 1996. 35:234–236.

7. Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology. 2005. 209:209–216.